A detailed history of Lmr Partners LLP transactions in Galapagos Nv stock. As of the latest transaction made, Lmr Partners LLP holds 10,768 shares of GLPG stock, worth $276,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,768
Previous 10,768 -0.0%
Holding current value
$276,091
Previous $266,000 16.54%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$36.5 - $48.0 $393,032 - $516,864
10,768 New
10,768 $416,000
Q2 2022

Aug 15, 2022

SELL
$52.3 - $71.59 $2.18 Million - $2.98 Million
-41,623 Reduced 83.67%
8,125 $453,000
Q1 2022

May 16, 2022

SELL
$51.32 - $68.5 $6.52 Million - $8.71 Million
-127,132 Reduced 71.87%
49,748 $3.09 Million
Q4 2021

Feb 14, 2022

BUY
$47.03 - $57.12 $3.62 Million - $4.39 Million
76,880 Added 76.88%
176,880 $9.75 Million
Q3 2021

Nov 15, 2021

BUY
$52.17 - $70.2 $5.22 Million - $7.02 Million
100,000 New
100,000 $5.26 Million

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.69B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.